Malignant mixed Müllerian tumor with small cell neuroendocrine differentiation: a case report and review of the literature.
BACKGROUND
Small cell neuroendocrine differentiation (NE) in malignant mixed Müllerian tumors (MMMTs) is a rare and unusual occurrence with very few previously reported cases. There is no consensus regarding its diagnosis, classification, and optimal treatment options.


METHODS
The authors report a patient with endometrial MMMT and NE differentiation who initially received comprehensive surgery followed by adjuvant chemotherapy containing cisplatin and etoposide. She further underwent metastasectomy and received carboplatin and paclitaxel for the relapse. She is still alive 12 months after the diagnosis. The authors performed a review of literature in order to characterize the clinical phenotype. These patients have a very aggressive disease. Median life expectancy seems to be less than a year.


CONCLUSIONS
It is reasonable to perform comprehensive staging surgery followed by adjuvant chemotherapy irrespective to stage of the disease.
T
T
Toptas
G
G
Tasova-Yildirim
S
S
Karaveli
T
T
Simsek
D000368:Aged; D018278:Carcinoma, Neuroendocrine / Q000473:pathology*; D018288:Carcinoma, Small Cell / Q000473:pathology*; D016889:Endometrial Neoplasms / Q000473:pathology*; D005260:Female; D006801:Humans; D018200:Mixed Tumor, Mullerian / Q000473:pathology*